NCT07321769

Brief Summary

In patients with complex cataracts, spatial abnormalities in the lens and its surrounding tissues-including both the anterior and posterior ocular segments-are often present. Due to the lack of precise preoperative assessment tools and standardized surgical protocols, these cases are associated with increased surgical complexity and difficulty, often leading to suboptimal visual outcomes. Therefore, this study explores a three-dimensional reconstruction method for the anterior segment based on swept-source optical coherence tomography (SS-OCT). By integrating imaging data from CT, B-scan ultrasound, and ultrasound biomicroscopy (UBM), a full three-dimensional model of the eye is constructed to enable objective and quantitative evaluation of its entire structure. This approach aims to provide valuable reference for surgical planning and prognostic assessment in lens diseases accompanied by ocular spatial structural abnormalities.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
1,200

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2020

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2020

Completed
5.9 years until next milestone

First Submitted

Initial submission to the registry

December 7, 2025

Completed
24 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
7 days until next milestone

First Posted

Study publicly available on registry

January 7, 2026

Completed
Last Updated

January 7, 2026

Status Verified

November 1, 2025

Enrollment Period

6 years

First QC Date

December 7, 2025

Last Update Submit

December 22, 2025

Conditions

Outcome Measures

Primary Outcomes (4)

  • Anterior Segment SS-OCT Quantitative Results

    Quantification of the anterior segment SS-OCT imaging results

    Preoperatively, and postoperatively at 1 week, 1 month, and 3 months

  • Computed tomography

    Quantification of ocular CT imaging results

    Preoperatively, and postoperatively at 1 week, 1 month, and 3 months

  • B-scan ultrasonography

    Quantification of the B-ultrasound imaging results of the eyes

    Preoperatively, and postoperatively at 1 week, 1 month, and 3 months

  • Ultrasound Biomicroscope

    Quantification of the results of ocular UBM examination

    Preoperatively, and postoperatively at 1 week, 1 month, and 3 months

Secondary Outcomes (2)

  • IOL tilt decentration ELP

    Preoperatively, and postoperatively at 1 week, 1 month, and 3 months

  • Surgical Record

    During the operation

Study Arms (6)

Toward 3D Modeling for Lens Disorders Associated with Congenital Anomalies

Part I: Exploration and research on full three-dimensional modeling in the diagnosis and treatment of lens diseases with congenital developmental anomaliesa

Toward 3D Modeling for Reconstructive Management of Ocular Trauma

Part II: Exploration and research on full three-dimensional modeling for the reconstruction and treatment of ocular trauma

Toward 3D Modeling for IOL Spatial Positioning

Part III: Exploration and research on full three-dimensional modeling for the spatial positioning of pseudophakic eyes

Toward 3D Modeling for Cataracts with Iris/Pupillary Abnormalities

Part IV: Exploration and research on full three-dimensional modeling for cataract patients with iris or pupillary abnormalities

Toward 3D Modeling for Cataracts with Posterior Segment Diseases

Part V: Exploration and research on full three-dimensional modeling for the management and treatment of cataract patients with posterior segment diseases

Normal Control Group

Exploration and research on full three-dimensional modeling for individuals with no significant structural ocular diseases served as the normal control group.

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

The data for this project was collected from patients who visited the Second Affiliated Hospital, School of Medicine, Zhejiang University from January 1, 2020 to December 31, 2025.

You may qualify if:

  • Part I:Toward 3D Modeling for Lens Disorders Associated with Congenital Anomalies
  • \) Diagnosed with lens disorders such as lens subluxation or deformity via imaging (slit-lamp, UBM) or clinical examination, combined with conditions such as megalocornea, microcornea, nanophthalmos, keratoconus, or iris coloboma; 2) Presence of imageable ocular structures; 3) Able to cooperate with and complete relevant examinations including B-scan ultrasound, UBM, and anterior segment SS-OCT.
  • Part II: Toward 3D Modeling for Reconstructive Management of Ocular Trauma 1) Diagnosed with previous or stabilized corneal trauma, traumatic cataract, or iris injury, with or without associated vitreous traction or retinal damage; 2) Patients with open globe injuries that have been managed, with closed wounds and no endophthalmitis; 3) Able to cooperate with and complete relevant examinations including B-scan ultrasound, UBM, anterior segment SS-OCT, and CT.
  • Part III:Toward 3D Modeling for IOL Spatial Positioning 1) Patients who have undergone cataract extraction with intraocular lens (IOL) implantation (in-the-bag or scleral-fixated); 2) Stable IOL position post-implantation with clear documentation of IOL parameters; 3) Able to cooperate with and complete relevant examinations including B-scan ultrasound, UBM, and anterior segment SS-OCT.
  • Part IV: Toward 3D Modeling for Cataracts with Iris/Pupillary Abnormalities
  • Patients with iris morphological or positional abnormalities due to previous uveitis, trauma, or developmental anomalies (e.g., iris atrophy, synechiae, iridodialysis, polycoria, pupillary membrane remnants); 2) Able to cooperate with and complete relevant examinations including B-scan ultrasound, UBM, and anterior segment SS-OCT.
  • Part V: Toward 3D Modeling for Cataracts with Posterior Segment Diseases
  • \) Patients with various posterior segment vitreoretinal diseases (e.g., vitreous traction or proliferation, macular hole, epiretinal membrane), with or without anterior segment spatial structural abnormalities; 2) Able to cooperate with and complete relevant examinations including B-scan ultrasound, UBM, and anterior/posterior segment SS-OCT.
  • Part VI: Normal Control Group
  • No significant structural ocular diseases; 2) Healthy fellow eyes of unilateral ocular trauma patients from Part II, with no notable anterior or posterior segment abnormalities; 3) Able to cooperate with and complete relevant examinations including B-scan ultrasound, UBM, anterior/posterior segment SS-OCT, and CT.

You may not qualify if:

  • Part I: Toward 3D Modeling for Lens Disorders Associated with Congenital Anomalies
  • \) Concurrent open globe injury or severe ocular deformity; 2) Excessive corneal opacity or severe edema resulting in inadequate image quality; 3) Severe dry eye or tear film abnormalities affecting imaging;4) Severe ocular structural deformity preventing effective 3D model reconstruction; 5) Severe systemic disease precluding tolerance of the examination; 6) Contraindications to B-scan ultrasound or UBM, conditions impairing imaging, or allergy to coupling gel.
  • Part II: Toward 3D Modeling for Reconstructive Management of Ocular Trauma
  • \) Unmanaged open globe injury or severe ocular deformity; 2) Severe systemic disease precluding tolerance of the examination; 3) Contraindications to CT imaging (e.g., metallic implants in the head/face region, pregnancy, lactation) or history of contrast medium allergy/adverse reactions.
  • Part III: Toward 3D Modeling for IOL Spatial Positioning
  • \) Unclear IOL position or documented implantation failure; 2) Corneal opacity or severe pupillary abnormality affecting imaging; 3) IOL instability due to intra- or postoperative complications preventing imaging;4) Open globe injury or severe ocular deformity; 5) Severe systemic disease precluding tolerance of the examination; 6) Contraindications to B-scan ultrasound or UBM, conditions impairing imaging, or allergy to coupling gel.
  • Part IV: Toward 3D Modeling for Cataracts with Iris/Pupillary Abnormalities
  • \) Corneal opacity or hyphema preventing imaging; 2) Severe global ocular deformity precluding imaging; 3) Severe systemic disease precluding tolerance of examination or follow-up; 4) Contraindications to B-scan ultrasound or UBM, conditions impairing imaging, or allergy to coupling gel.
  • Part V: Toward 3D Modeling for Cataracts with Posterior Segment Diseases
  • \) Severe structural deformity of both anterior and posterior segments preventing effective 3D model reconstruction; 2) Severe systemic disease precluding tolerance of examination or follow-up; 3) Contraindications to B-scan ultrasound or UBM, conditions impairing imaging, or allergy to coupling gel.
  • Part VI: Normal Control Group 1) History of severe ocular trauma or ocular surgery; 2) Conditions affecting imaging quality, including corneal opacity, severe dry eye, tear film abnormalities, anterior segment disease, or significant retinal pathology; 3) Severe systemic disease precluding tolerance of the examination; 4) Contraindications to CT imaging (e.g., metallic implants in the head/face region, pregnancy, lactation) or history of contrast medium allergy/adverse reactions.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Second Affiliated Hospital, Zhejiang University School of Medicine,

Hangzhou, Zhejiang, 310009, China

RECRUITING

MeSH Terms

Conditions

Lens Diseases

Condition Hierarchy (Ancestors)

Eye Diseases

Study Officials

  • Wen Xu, Phd

    Second Affiliated Hospital, School of Medicine, Zhejiang University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 7, 2025

First Posted

January 7, 2026

Study Start

January 1, 2020

Primary Completion

December 31, 2025

Study Completion

December 31, 2025

Last Updated

January 7, 2026

Record last verified: 2025-11

Locations